Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Steve Madden Partners with RunDTC & Contentstack for eCommerce Transformation on Shopify
-
Teledyne’s new 2.5 GigE Vision line scan camera delivers industry-leading performance in a cost-effective package
-
Medera Receives DSMB Clearance to Initiate Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial for SRD-001 Gene Therapy in Heart Failure with Reduced Ejection Fraction
-
Nitrase Therapeutics Unveils Protein with Newly Characterized Enzymatic Function Involved in the Pathogenesis of Parkinson’s Disease
-
Axonius Unveils Unified Identity Management & Security Solution to Centralize IAM Program Operations
-
Esperion Aligns with U.S. Food and Drug Administration to Initiate Phase 3 Clinical Trials of Bempedoic Acid in Pediatric Heterozygous and Homozygous Familial Hypercholesterolemia
-
Yara refinances revolving credit facility with 11 banks
-
Resolutions taken by the Annual General Meeting of SATO Corporation
-
Transfer of Huhtamäki Oyj's own treasury shares
-
Endeavour Announces Renewal of Normal Course Issuer Bid
-
ECD Auto Design Now Accepting Cryptocurrency Payments via BitPay
-
$MUBARAK and $MUBARAKAH Now Available for Trading on BYDFi
-
Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain
-
Alm. Brand A/S – Candidates for the Board of Directors 2025
-
Alm. Brand A/S – Chairman Jørgen Hesselbjerg Mikkelsen will not be standing for re-election at upcoming annual general meeting
-
Alarum Technologies Announces Fourth Quarter and Annual 2024 Results
-
Duke Robotics Reports 2024 Financial Results and Provides Business Update
-
Revival Gold Enters Marketing Services Agreement
-
Antitrust and Industrial Organization Expert Matthew Backus Affiliates with Compass Lexecon
-
Knight Therapeutics Reports Fourth Quarter and Year-End 2024 Results
-
Aqua-Tots Dives Deeper into New Jersey with Fifth Location Coming Mid-April to North Bergen
-
Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community
-
Plus Therapeutics Introduces REYOBIQ™, FDA-Accepted Proprietary Name for Lead Drug Candidate
-
Quantum BioPharma Continues to Grow Its Crypto Assets and Diversify Its Treasury With the Purchase of Another USD $1,500,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies
-
Highwire Achieves Double-Digit Growth in 2024, Elevates Michael Byrnes to Chief Growth Officer
-
Nayax Introduces Innovative State-of-Charge Feature for EV Kiosk, Elevating EV Charging Experience
-
InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones
-
3 E Network Technology Group Limited Announces Strategic Equity Investment in HashBeaver to Accelerate Blockchain Innovation
-
Quantum BioPharma Continues to Grow Its Crypto Assets and Diversify Its Treasury With the Purchase of Another USD $1,500,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies
-
Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans
-
XOMA Royalty Declares Quarterly Preferred Stock Dividends
-
Nykredit Realkredit A/S – annual general meeting 2025
-
Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments
-
Chris Miller, Former Acting U.S. Secretary of Defense Appointed by President Trump, Joins the Draganfly Board of Directors
-
Emerging Markets Report: Ceilings & Floors
-
Emerging Markets Report: Ceilings & Floors
-
Clearside Biomedical’s Lead Clinical Program CLS-AX in Wet AMD and Suprachoroidal Delivery Platform Highlighted at the 2025 Wet AMD & Diabetic Eye Disease Summit
-
British King Gold Project: Filing of NI43-101 Technical Report
-
MEXC Introduces Bedrock (BR) Listing with Spot & Futures Trading, Offering 150,000 USDT to Power Next-Gen DeFi Restaking
-
MEXC Introduces Bedrock (BR) Listing with Spot & Futures Trading, Offering 150,000 USDT to Power Next-Gen DeFi Restaking
-
Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update
-
Monte Rosa Therapeutics Announces Fourth Quarter 2024 Financial Results and Provides Corporate Update Including New Clinical Results from MRT-6160 and MRT-2359 Programs
-
Plymouth Industrial REIT Expands Portfolio in Atlanta and Cincinnati
-
First Helium Announces Shallow Heavy Oil Discovery
-
Wugen Announces Dosing of First Patients in Pivotal Trial of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007
-
Koelis Announces Innovative Products at EAU 2025 enhancing MRI Fusion Biopsy Workflows and promoting Focal Therapy in Prostate Cancer
-
Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on March 28, 2025
-
RYVYL Secures Major Payments-as-a-Service Contracts, Set to Onboard Nearly One Million New Accounts in the next 12 Months
-
KFC easily remains the fried chicken champion in showdown with AI
-
Enthusiast Gaming’s Addicting Games Partners with ByteBrew to Provide Enhanced Analytics for its Web Game Developers
